×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Lotus Eye Hospital And Institu | 137.04 | 5.45 | 135.17 | 0.26 | 246.0 | 378.0 |
| AAREY DRUGS & PHARMACEUTICALS | 1037.6 | 13.71 | 1022.08 | 0.48 | 223 | 53.5 |
| PHARMAIDS PHARMACEUTICALS LTD. | NA | NA | NA | NA | 204 |
Lotus Eye Hospital And Institute Limited, with Security Code 532998, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.2 | 12.6 | 12.7 | 12.0 | 10.9 | 12.9 | 12.9 | 12.2 | 11.5 | 13.5 |
| Expenses | 9.8 | 10.2 | 10.9 | 10.5 | 10.1 | 11.2 | 11.8 | 11.5 | 10.4 | 12.0 |
| Operating Profit | 1.4 | 2.4 | 1.8 | 1.6 | 0.8 | 1.7 | 1.1 | 0.8 | 1.1 | 1.5 |
| OPM % | 12.45% | 18.94% | 14.25% | 13.12% | 6.96% | 12.92% | 8.88% | 6.44% | 9.47% | 10.93% |
| Other Income | 0.4 | 0.3 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.2 | 0.5 | 0.2 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.8 | 0.7 | 0.9 | 1.0 | 1.1 | 1.1 | 1.2 | 1.3 | 0.6 | 0.8 |
| Profit before tax | 1.0 | 1.9 | 1.2 | 0.9 | 0.0 | 0.9 | 0.1 | -0.4 | 0.9 | 0.7 |
| Tax % | -31.9% | -28.1% | -28.3% | -26.9% | 380% | 27.2% | 6.4% | 43.9% | -59.4% | 25.3% |
| Net Profit | 0.6 | 1.4 | 0.9 | 0.7 | 0.0 | 0.6 | 0.1 | -0.2 | 0.3 | 0.5 |
| EPS in Rs | 0.31 | 0.67 | 0.41 | 0.32 | 0.01 | 0.3 | 0.05 | -0.11 | 0 | 0.26 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 5% |
| 3 Years: | 14% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 54% |
| 5 Years: | 33% |
| 3 Years: | 24% |
| TTM: | -86% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 24% |
| 3 Years: | 12% |
| 1 Year: | 20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|